{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05901714",
            "orgStudyIdInfo": {
                "id": "IM026-026"
            },
            "organization": {
                "fullName": "Bristol-Myers Squibb",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of Midazolam",
            "officialTitle": "An Open-label, Single-sequence, Drug-drug Interaction Study in Healthy Participants to Assess the Effect of Phenytoin on the Pharmacokinetics of a Single Oral Dose of Afimetoran (BMS-986256) (Part 1) and the Effect of Steady-state Afimetoran on the Pharmacokinetics of Midazolam (Part 2)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-to-assess-the-effect-of-phenytoin-on-the-drug-levels-of-afimetoran-and-the-effect-of-afimetoran-on-the-drug-levels-of-midazolam"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-06-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-10-17",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2023-10-17",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-05",
            "studyFirstSubmitQcDate": "2023-06-05",
            "studyFirstPostDateStruct": {
                "date": "2023-06-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-07-12",
            "lastUpdatePostDateStruct": {
                "date": "2023-07-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Bristol-Myers Squibb",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will consist of 2 parts. The study will evaluate whether administration of phenytoin impacts the single-dose drug levels of afimetoran and BMT-271199 (Part 1) and will evaluate whether multiple administrations of afimetoran impact the drug levels of midazolam and 1-hydroxymidazolam (Part 2)."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy Participants"
            ],
            "keywords": [
                "BMS-986256",
                "Afimetoran",
                "Midazolam",
                "CYP3A4",
                "Phenytoin"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part 1: Afimetoran followed by phenytoin + afimetoran",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Afimetoran",
                        "Drug: Phenytoin"
                    ]
                },
                {
                    "label": "Part 2: Midazolam followed by afimetoran + midazolam",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Afimetoran",
                        "Drug: Midazolam"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Afimetoran",
                    "description": "Specified dose on specified days",
                    "armGroupLabels": [
                        "Part 1: Afimetoran followed by phenytoin + afimetoran",
                        "Part 2: Midazolam followed by afimetoran + midazolam"
                    ],
                    "otherNames": [
                        "BMS-986256"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Phenytoin",
                    "description": "Specified dose on specified days",
                    "armGroupLabels": [
                        "Part 1: Afimetoran followed by phenytoin + afimetoran"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Midazolam",
                    "description": "Specified dose on specified days",
                    "armGroupLabels": [
                        "Part 2: Midazolam followed by afimetoran + midazolam"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Maximum observed plasma concentration (Cmax)",
                    "description": "Parts 1 and 2",
                    "timeFrame": "Up to 53 days"
                },
                {
                    "measure": "Area under the plasma concentration-time curve from time zero to time of the last quantifiable concentration (AUC[0-T])",
                    "description": "Parts 1 and 2",
                    "timeFrame": "Up to 53 days"
                },
                {
                    "measure": "Area under the plasma concentration-time curve from time zero extrapolated to infinite time (AUC[INF])",
                    "description": "Parts 1 and 2",
                    "timeFrame": "Up to 53 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Time to attain maximum observed plasma concentration (Tmax)",
                    "description": "Parts 1 and 2",
                    "timeFrame": "Up to 53 days"
                },
                {
                    "measure": "Terminal half-life (T-Half)",
                    "description": "Parts 1 and 2",
                    "timeFrame": "Up to 53 days"
                },
                {
                    "measure": "Apparent total body clearance of the drug from the plasma (CLT/F)",
                    "description": "Parts 1 and 2",
                    "timeFrame": "Up to 53 days"
                },
                {
                    "measure": "Number of participants with adverse events (AEs)",
                    "description": "Parts 1 and 2",
                    "timeFrame": "Up to 124 days"
                },
                {
                    "measure": "Number of participants with clinical laboratory abnormalities",
                    "description": "Parts 1 and 2",
                    "timeFrame": "Up to 66 days"
                },
                {
                    "measure": "Number of participants with physical examination abnormalities",
                    "description": "Parts 1 and 2",
                    "timeFrame": "Up to 66 days"
                },
                {
                    "measure": "Number of participants with vital sign abnormalities",
                    "description": "Parts 1 and 2",
                    "timeFrame": "Up to 66 days"
                },
                {
                    "measure": "Number of participants with electrocardiogram (ECG) abnormalities",
                    "description": "Parts 1 and 2",
                    "timeFrame": "Up to 66 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Body mass index (BMI) of 19.0 kilograms per meter squared (kg/m\\^2) to 32.0 kg/m2, inclusive, and body weight \u2265 55 kg, at screening.\n\nExclusion Criteria:\n\n* Any significant acute or chronic medical illness or any other condition listed as a contraindication in the phenytoin (Part 1) or midazolam (Part 2) package inserts.\n* History of seizure (including simple febrile seizure), epilepsy, severe head injury (including concussion), multiple sclerosis, or other known neurological condition which the investigator considers to be clinically significant.\n* Current or recent (within 3 months of study intervention administration) GI disease that could impact upon the absorption of study intervention.\n\nOther protocol-defined inclusion/exclusion criteria apply.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "BMS Study Connect Contact Center www.BMSStudyConnect.com",
                    "role": "CONTACT",
                    "phone": "855-907-3286",
                    "email": "Clinical.Trials@bms.com"
                },
                {
                    "name": "First line of the email MUST contain the NCT# and Site #.",
                    "role": "CONTACT"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Bristol-Myers Squibb",
                    "affiliation": "Bristol-Myers Squibb",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Syneos Health Clinical Research Services, Llc",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "David Wyatt, Site 0001",
                            "role": "CONTACT",
                            "phone": "305-547-5857"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "BMS Clinical Trial Information",
                    "url": "https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html"
                },
                {
                    "label": "BMS Clinical Trial Patient Recruiting",
                    "url": "https://www.bmsstudyconnect.com/us/en/home.html"
                },
                {
                    "label": "FDA Safety Alerts and Recalls",
                    "url": "https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria. Additional information regarding Bristol Myers Squibb's data sharing policy and process can be found at: https://www.bms.com/researchers-and-partners/clinical-trials-and-research/disclosure-commitment.html"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010672",
                    "term": "Phenytoin"
                },
                {
                    "id": "D000008874",
                    "term": "Midazolam"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000759",
                    "term": "Adjuvants, Anesthesia"
                },
                {
                    "id": "D000006993",
                    "term": "Hypnotics and Sedatives"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000014151",
                    "term": "Anti-Anxiety Agents"
                },
                {
                    "id": "D000014149",
                    "term": "Tranquilizing Agents"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                },
                {
                    "id": "D000018686",
                    "term": "Anesthetics, Intravenous"
                },
                {
                    "id": "D000018681",
                    "term": "Anesthetics, General"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                },
                {
                    "id": "D000018757",
                    "term": "GABA Modulators"
                },
                {
                    "id": "D000018682",
                    "term": "GABA Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000927",
                    "term": "Anticonvulsants"
                },
                {
                    "id": "D000061567",
                    "term": "Voltage-Gated Sodium Channel Blockers"
                },
                {
                    "id": "D000026941",
                    "term": "Sodium Channel Blockers"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000065694",
                    "term": "Cytochrome P-450 CYP1A2 Inducers"
                },
                {
                    "id": "D000065693",
                    "term": "Cytochrome P-450 Enzyme Inducers"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11845",
                    "name": "Midazolam",
                    "asFound": "Course",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13577",
                    "name": "Phenytoin",
                    "asFound": "Binge",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4089",
                    "name": "Adjuvants, Anesthesia",
                    "relevance": "LOW"
                },
                {
                    "id": "M10043",
                    "name": "Hypnotics and Sedatives",
                    "relevance": "LOW"
                },
                {
                    "id": "M16905",
                    "name": "Anti-Anxiety Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                },
                {
                    "id": "M20766",
                    "name": "Anesthetics, Intravenous",
                    "relevance": "LOW"
                },
                {
                    "id": "M20761",
                    "name": "Anesthetics, General",
                    "relevance": "LOW"
                },
                {
                    "id": "M20827",
                    "name": "GABA Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4246",
                    "name": "Anticonvulsants",
                    "relevance": "LOW"
                },
                {
                    "id": "M23177",
                    "name": "Sodium Channel Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M30025",
                    "name": "Diuretics, Potassium Sparing",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AdjAn",
                    "name": "Adjuvants, Anesthesia"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ChanBlk",
                    "name": "Channel Blockers"
                },
                {
                    "abbrev": "AntiConv",
                    "name": "Anticonvulsants"
                }
            ]
        }
    },
    "hasResults": false
}